Galectin-3 is an independent predictor of postoperative atrial fibrillation and survival after elective cardiac surgery.

[1]  U. Bracale,et al.  Galectin-3 in Cardiovascular Diseases , 2020, International journal of molecular sciences.

[2]  A. MacKinnon,et al.  The therapeutic potential of galectin-3 inhibition in fibrotic disease. , 2020, The international journal of biochemistry & cell biology.

[3]  Hong-liang Zhang,et al.  Preprocedural circulating galectin-3 and the risk of mortality after transcatheter aortic valve replacement: a systematic review and meta-analysis , 2020, Bioscience reports.

[4]  Jeroen J. Bax,et al.  2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). , 2020, European heart journal.

[5]  Jeremiah R. Brown,et al.  Galectin-3 as a Predictor of Long-term Survival after Isolated Coronary Artery Bypass Grafting Surgery. , 2020, The Annals of thoracic surgery.

[6]  H. Canpınar,et al.  Serum galectin-3 level predicts early recurrence following successful direct-current cardioversion in persistent atrial fibrillation patients. , 2019, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[7]  L. Fauchier,et al.  Galectin-3 level predicts response to ablation and outcomes in patients with persistent atrial fibrillation and systolic heart failure , 2018, PloS one.

[8]  L. Fauchier,et al.  Galectin-3 in Atrial Fibrillation: Mechanisms and Therapeutic Implications , 2018, International journal of molecular sciences.

[9]  L. Lavra,et al.  Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z , 2018, International journal of molecular sciences.

[10]  M. Borggrefe,et al.  Galectin-3 Reflects Left Atrial Function being Assessed by Cardiac Magnetic Resonance Imaging. , 2017, Clinical Laboratory.

[11]  G. Novo,et al.  Short-term Changes in Gal 3 Circulating Levels After Acute Myocardial Infarction. , 2016, Archives of medical research.

[12]  Y. Başaran,et al.  Postoperative Atrial Fibrillation after Coronary Artery Bypass Grafting Surgery: A Two-dimensional Speckle Tracking Echocardiography Study. , 2016, Heart, lung & circulation.

[13]  Jesper Hastrup Svendsen,et al.  Multimodality Cardiac Imaging for the Assessment of Left Atrial Function and the Association With Atrial Arrhythmias , 2016, Circulation. Cardiovascular imaging.

[14]  E. Saloux,et al.  Preoperative plasma aldosterone and the risk of atrial fibrillation after coronary artery bypass surgery: a prospective cohort study , 2016, Journal of hypertension.

[15]  F. Morady,et al.  Galectin-3 Regulates Atrial Fibrillation Remodeling and Predicts Catheter Ablation Outcomes , 2016, JACC. Basic to translational science.

[16]  L. Tokgozoglu,et al.  The Association of Serum Galectin‐3 Levels with Atrial Electrical and Structural Remodeling , 2015, Journal of cardiovascular electrophysiology.

[17]  L. Tokgozoglu,et al.  Effects of persistent atrial fibrillation on serum galectin-3 levels. , 2015, The American journal of cardiology.

[18]  U. Schotten,et al.  A prospective randomized controlled trial on the incidence and predictors of late-phase postoperative atrial fibrillation up to 30 days and the preventive value of biatrial pacing. , 2014, Heart rhythm.

[19]  D. Levy,et al.  Galectin 3 and incident atrial fibrillation in the community. , 2014, American heart journal.

[20]  Bertram Pitt,et al.  Genetic and Pharmacological Inhibition of Galectin-3 Prevents Cardiac Remodeling by Interfering With Myocardial Fibrogenesis , 2013, Circulation. Heart failure.

[21]  Michael F Swartz,et al.  Elevated pre-operative serum peptides for collagen I and III synthesis result in post-surgical atrial fibrillation. , 2012, Journal of the American College of Cardiology.

[22]  D. Levy,et al.  Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community. , 2012, Journal of the American College of Cardiology.

[23]  P. McCullough,et al.  Galectin-3: a novel blood test for the evaluation and management of patients with heart failure. , 2011, Reviews in cardiovascular medicine.

[24]  A. Ahlsson,et al.  Postoperative atrial fibrillation in patients undergoing aortocoronary bypass surgery carries an eightfold risk of future atrial fibrillation and a doubled cardiovascular mortality. , 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[25]  Yi-Lwun Ho,et al.  The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[26]  D. J. Veldhuisen,et al.  Galectin‐3: a novel mediator of heart failure development and progression , 2009, European journal of heart failure.

[27]  O. Carretero,et al.  N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin. , 2009, American journal of physiology. Heart and circulatory physiology.

[28]  Yigal M. Pinto,et al.  Galectin-3 Marks Activated Macrophages in Failure-Prone Hypertrophied Hearts and Contributes to Cardiac Dysfunction , 2004, Circulation.

[29]  J. Mathew,et al.  A multicenter risk index for atrial fibrillation after cardiac surgery. , 2004, JAMA.

[30]  O. Vuolteenaho,et al.  Prediction of atrial fibrillation after coronary artery bypass grafting by measuring atrial peptide levels and preoperative atrial dimensions. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[31]  W. Stevenson,et al.  Atrial Fibrillation after Cardiac Surgery , 2001, Annals of Internal Medicine.

[32]  Samer A M Nashef,et al.  EuroSCORE II. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[33]  Fu-Tong Liu,et al.  Role of galectin-3 in human pulmonary fibrosis. , 2007, Allergology international : official journal of the Japanese Society of Allergology.